-
Australia
|
-
17 May 2013
|
-
News
Singapore: Agilent Technologies extended its collaboration with the University of Sydney, Australia, by providing advanced analytical instrumentation to...
Read more
-
Australia
|
-
16 May 2013
|
-
News
Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted, oral inhibitor of PI3K...
Read more
-
Australia
|
-
14 May 2013
|
-
Analysis
Increase in aging population along with rising burden of non communicable diseases in Australia have been putting pressure on the government to offer drugs...
Read more